AdvertiseDonate
Wed, Nov 4, 2026AnchorageSeattleFort WorthJacksonvilleColumbusWashingtonBostonDetroit
Viral Newsline · 3001 Porcupine Drive, Anchorage, AK 99501

Warhound Secures Funding for Engineered Military Canines

The startup plans to clone top-performing dogs to reduce breed-specific health issues, with the first litter expected in early 2027.

By Hana Gray ·

Illustration for: Warhound Secures Funding for Engineered Military Canines
Illustration generated for this article, not a news photograph.

Warhound has raised $200 million to develop gene-edited dogs for the United States military.

The funding supports a joint venture between Ben Lamm of Colossal Biosciences and Palmer Luckey of Anduril. Lamm stated that the team has already begun editing genes from cell samples taken from high-performing donor animals. These donors include Belgian Malinois, labradors, and shepherds currently serving in military, police, and first responder roles across the country. The genetic material will be modified by scientists at Colossal before the animals are cloned.

The initial phase of research targets common health issues in these breeds. The goal is to lower the probability of dogs developing hip dysplasia or certain types of cancer. Lamm indicated that future iterations may include genetic modifications designed to improve speed, agility, or olfactory capabilities. The first batch of these engineered dogs is scheduled for birth in early 2027. Once born, the animals will undergo training for standard working tasks such as bomb detection and search and rescue operations.

The partnership leverages distinct expertise from its two primary backers. Luckey previously founded Oculus VR and built the Oculus Rift headset. His defense firm, Anduril, won a US Army contract to develop a next-generation battlefield intelligence system with Palantir. Anduril will focus on the physical equipment for Warhound’s dogs, including goggles, vests, and body armor. The company will not create cyborg dogs but will instead design protective tools and the software that operates them.

Lamm’s Colossal Biosciences is known for de-extinction projects, including efforts to revive the dire wolf and woolly mammoth. While Colossal holds equity in the new venture, Lamm serves on the board. Luckey is a partner in the business but does not hold a stake in the startup. David Spirk, formerly of Palantir, serves as the chief executive officer of Warhound.

The company aims to produce healthier and more capable service animals for defense applications. The project combines biological engineering with advanced protective gear. The first cloned dogs will be available for service in early 2027.

Source: Engadget

More Tech · Report a business · Got a Story?

Get Viral Newsline in your inboxToday’s news, without the noise. Free, a few times a week, unsubscribe any time.

Related stories

Get Viral Newsline in your inboxToday’s news, without the noise. Free, a few times a week, unsubscribe any time.